Pharma Journalist 8801 posts 0 comments

Adaptimmune Therapeutics plc and Cryoport, Inc. announce a 3-year agreement to ensure safe and fully monitored transport of Adaptimmune’s cell therapies. Optimizing manufacturing and…
Read More...

Ionis Pharmaceuticals, Inc. announced that the company has been notified by its partner Bayer about the decision to advance IONIS-FXI-LRx following positive clinical results.…
Read More...

bluebird bio, Inc. and Novo Nordisk A/S (NVO) announced that they have entered into a research collaboration to jointly develop next-generation in vivo genome editing treatments for…
Read More...

Viela Bio, Inc. and Mitsubishi Tanabe Pharma Corporation announced a collaboration focused on the development and commercialization of inebilizumab – Viela’s humanized anti-CD19…
Read More...

Alcami Corporation announced the launch of its new rapid sterility offering, a service that leverages cutting-edge microbiological testing technology to deliver significantly faster…
Read More...

Hoth Therapeutics, Inc. a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as…
Read More...

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announces it has dosed its…
Read More...

Novartis announced that the U.S. Food and Drug Administration (FDA) approved Beovu (brolucizumab) injection, also known as RTH258 for the treatment of wet age-related macular…
Read More...

GlaxoSmithKline plc announced a five-year collaboration with Lyell Immunopharma, a San Francisco biotechnology company, to develop new technologies to improve cell therapies for cancer…
Read More...

SMi Reports: Jessica Shull from Digital Therapeutics Alliance to present at Disruptive Technologies in Pharma conference in London on the 20th and 21st January The highly anticipated…
Read More...